Clinical Trial Update: A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060) [Phase 2]

View source ↗

Summary

Phase 2 study MK-8591B-060 evaluating once-weekly Islatravir and Ulonivirine in virologically suppressed adults with HIV-1; the trial is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Islatravir (Islatravir)
• Ulonovirine (ulonovirine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Immunodeficiency Virus Type 1 (HIV-1) Infection | Phase 2 | Status: ACTIVE_NOT_RECRUITING